Table 5 NG prevalence scenarios using the minimum and maximum of the observed site prevalence and these values plus or minus 0.05 (when the subtraction of the fixed value from the minimum observed prevalence yielded a negative result, we reduce the fixed value to 0.01)
Pharynx | Rectum | Urine | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pooled Sensitivity | Pooled Specificity | Scenarios | PPV | NPV | Pooled Sensitivity | Pooled Specificity | Scenarios | PPV | NPV | Pooled Sensitivity | Pooled Specificity | Scenarios | PPV | NPV |
0,7587 | 0,9877 | 0,0303 | 0,6584 | 0,9924 | 0,8968 | 0,9955 | 0,0303 | 0,8616 | 0,9968 | 0,9143 | 0,9975 | 0,0078 | 0,7419 | 1,0000 |
| Â | Â | 0,0403 | 0,7215 | 0,9898 | Â | Â | 0,0503 | 0,9135 | 0,9945 | Â | Â | 0,0128 | 0,8258 | 1,0000 |
Prevalence range | 0,0974 | 0,8694 | 0,9743 | Prevalence range | 0,1026 | 0,9580 | 0,9883 | Prevalence range | 0,0268 | 0,9097 | 0,9999 | |||
0,0403 | 0,0974 | 0,1474 | 0,9143 | 0,9595 | 0,0503 | 0,1026 | 0,1526 | 0,9729 | 0,9817 | 0,0128 | 0,0268 | 0,0768 | 0,9682 | 0,9998 |